New maintenance therapy shows promise in preventing relapse after transplant for T-Cell cancers
Disease control
Completed
This study tested whether a low dose of the drug chidamide, given after a stem cell transplant, can help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. Forty-four participants received the treatment to see how long they stayed cancer-free and wha…
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC